Showing 961-970 of 18562 results for "".
A Look at Immunizations Through Time
https://reachmd.com/programs/covid-19-frontlines/a-look-at-immunizations-through-time/11580/Immunization techniques have been evolving since the 1100s. Could the techniques of the past help us in our current hunt for a COVID-19 vaccine?Innovations in Less-Invasive Epilepsy Surgery
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/innovations-in-less-invasive-epilepsy-surgery/39963/Recent developments in epilepsy surgery underscore a growing trend toward reduced invasiveness and expanded clinical indications.Dr. Google Is a Liar
https://reachmd.com/programs/book-club/dr-google-liar/10612/With many patients turning to the internet for the answer to their symptoms and ailments, how can we as healthcare providers win the information war?New AMA President Dr. J. James Rohack's Inauguration Address
https://reachmd.com/programs/conference-coverage/new-ama-president-dr-j-james-rohacks-inauguration-address/4687/The American Medical Association (AMA) has inaugurated Dr. J. James Rohack, a cardiologist from Bryan, Texas, as the Association's 164th president. In his inaugural address as AMA president, Dr. Rohack covered a range of issues central to the ongoing debate over healthcare reform in the United StateIntegrating Perspectives: The Value of Patient and Caregiver Input
https://mededonthego.com/programs/cme/integrating-perspectives-the-value-of-patient-and-caregiver-input/35883/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
https://reachmd.com/programs/cme/implementing-the-latest-diagnostic-and-treatment-approaches-for-generalized-myasthenia-gravis/32961/Examine FcRn inhibitors in gMG with expert discussion on mechanisms, clinical trial results, therapeutic use, and individualized treatment approaches.Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
https://reachmd.com/programs/cme/optimizing-igan-care-achieving-lower-proteinuria-targets-with-combination-therapy/26631/Review data on combination therapy with sparsentan and SGLT2 inhibitors to achieve lower proteinuria in patients with IgA nephropathy.Clinical Criteria and Imaging Strategies for B7-H3–Directed ADCs in ES-SCLC
https://reachmd.com/programs/cme/clinical-criteria-and-imaging-strategies-for-b7-h3directed-adcs-in-es-sclc/39977/Explore recent clinical data on B7-H3 ADCs in ES-SCLC, with expert insights on biological rationale, efficacy outcomes, safety profiles, and patient selection.Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
https://reachmd.com/programs/cme/understanding-igan-fsgs-pathophysiology-and-emerging-therapies/14974/Hear experts discuss how emerging therapies for IgAN and FSGS may achieve proteinuria remission and shape clinical treatment decisions for patients.In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience
https://reachmd.com/programs/cme/in-your-waiting-room-the-virtual-ibs-c-patient-clinical-experience/14955/What else can you do for your patients with IBS-C whose current therapies aren’t enough? Join our experts to explore the stories of 3 patients.